发明名称 ANTI-THROMBOSIS AGENT
摘要 PROBLEM TO BE SOLVED: To obtain a new compound having good peroral vital utility and highly useful as a selectively reversible thrombin inhibitor. SOLUTION: This new compound is expressed by formula I [R1 is H, a 1-4C alkyl or the like; R2 is H, methyl or the like; R3 is H, a 1-4C alkyl or the like; R4 is H or a 1-4C alkyl; R5 is H or a 1-4C alkyl; R6 is H, F, a 1-4C alkyl or the like; R7 is H, a 1-6C alkyl or the like when B is phenyl or the like; V is C or N; W and X are each CH, CF or the like; B-A is B-C(R8)(R9) (R and R are each H or the like; B is phenyl or the like) or the like] and is e.g. (R,S)-2-[3-[(2-amino-1-benzylethyl)amino]-6-methyl-2-oxo-1(2H)-pyridin yl]- N-(1H-indol-5-ylmethyl)acetamide. The compound of formula I is obtained by combining a compound of formula II with a heterocyclic amine of formula III.
申请公布号 JP2000063380(A) 申请公布日期 2000.02.29
申请号 JP19990229491 申请日期 1999.08.13
申请人 PFIZER INC 发明人 JULIAN BLAGG;ALAN DANIEL BROWN;ELIZABETH COLLET LOUISE GAUTIER;JULIAN DUNCAN SMITH;ANDREW BRIAN MACKELROY
分类号 A61K31/44;A61K31/4427;A61K31/443;A61K31/4439;A61K31/47;A61K31/495;A61K31/497;A61K31/535;A61K31/55;A61K38/00;A61K38/05;A61P7/00;A61P7/02;A61P9/00;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/14;C07D413/14;C07K5/06;C07K5/078;(IPC1-7):C07D401/14 主分类号 A61K31/44
代理机构 代理人
主权项
地址